TUMOR-ASSOCIATED MACROPHAGES: RELATIONSHIP WITH CLINICAL STATUS OF PATIENTS AND MOLECULAR BIOLOGICAL FEATURES OF BREAST CANCER
DOI:
https://doi.org/10.15407/exp-oncology.2025.02.197Keywords:
breast cancer, tumor-associated macrophages, disease courseAbstract
Background. Infiltration of the tumor microenvironment by macrophages plays a key role in the progression of breast cancer (BC), modulating tumor growth, angiogenesis, immunosuppression, and metastasis. However, the association between macrophage infiltration levels and the clinicopathological characteristics of BC, including the molecular subtype of the neoplasm and receptor status, remains insufficiently studied. Aim. To investigate the relationship between macrophage infiltration in BC tissue and the extent of tumor spread as well as the molecular profile of the neoplasms. Materials and Methods. Using immunohistochemistry, the level of infiltration of tumor tissue by CD68+ (total macrophages) and CD163+ (M2 phenotype macrophages) tumor-associated macrophages (TAMs) was assessed in the postoperative samples from 67 patients with BC stage I—II. Results. The level of CD68+ macrophage infiltration in BC tissue was associated with the disease stage (p = 0.004), tumor size (T category) (p = 0.026), and the presence of metastases in regional lymph nodes (p = 0.047). The highest number of CD163+ M2-like macrophages was recorded in poorly differentiated BC tissue (p = 0.024) and in neoplasms of the basal-like molecular subtype (p = 0.023). The lowest numbers of both CD68+ and CD163+ macrophages were detected in HER2/neu-positive tumors (p = 0.023). The data indicated that BC tumors classified as T2 and N1—N3 were characterized by an increased content of M1-polarized macrophages, whereas in basal-like BC and poorly differentiated tumors (G3), the M2 macrophage subpopulation predominated. This contributed to the formation of an immunosuppressive tumor phenotype and indicated the potential prognostic significance of macrophage infiltration in malignant breast neoplasms. Conclusions. The topology and quantitative characteristics of macrophage infiltration in tumor tissue are closely associated with the extent of BC spread and the molecular profile of the neoplasms. The CD68+/CD163+ cell ratio may reflect the balance between antitumor and immunosuppressive mechanisms within the microenvironment and be considered a potential prognostic marker.
References
Kosorok MR, Laber EB. Precision medicine. Annu Rev Stat Appl. 2019;6:263-286. https://doi.org/10.1146/annurev- statistics-030718-105251
Garattini L, Curto A, Freemantle N. Personalized medicine and economic evaluation in oncology: all theory and no practice? Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):733-738. https://doi.org/10.1586/14737167.2015.107 8239
Kalia M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015;64(3 Suppl 1): S16-S21. https://doi.org/10.1016/j.metabol.2014.10.027
Su M, Zhang Z, Zhou X, et al. Proteomics, personalized medicine and cancer. Cancers (Basel). 2021;13(11):2512. https://doi.org/10.3390/cancers13112512
Wang Q, Shao X, Zhang Y. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 2023;12:11149–11165. https://doi.org/10.1002/cam4.5698
Sabit H, Arneth B, Abdel-Ghany S, et al. Beyond cancer cells: how the tumor microenvironment drives cancer pro- gression. Cells. 2024;13(19):1666. https://doi.org/10.3390/cells13191666
Brassart-Pasco S, Brézillon S, Brassart B, et al. Tumor microenvironment: extracellular matrix alterations influence tumor progression. Front Oncol. 2020;10:397. https://doi.org/10.3389/fonc.2020.00397
Munir MT, Kay MK, Kang MH, et al. Tumor-associated macrophages as multifaceted regulators of breast tumor growth. Int J Mol Sci. 2021;22(12):6526. https://doi.org/10.3390/ijms22126526
Malfitano AM, Pisanti S, Napolitano F, et al. Tumor-associated macrophage status in cancer treatment. Cancers (Basel). 2020;12(7):1987. https://doi.org/10.3390/cancers12071987
Pan Y, Yu Y, Wang X, et al. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084. https://doi.org/10.3389/fimmu.2020.583084
Kumari N, Choi SH. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunothera- pies. J Exp Clin Cancer Res. 2022;41(1):68. https://doi.org/10.1186/s13046-022-02272-x
Fu LQ, Du WL, Cai MH, et al. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
Cell Immunol. 2020;353:104119. https://doi.org/10.1016/j.cellimm.2020.104119
Brierley JD, Gospodarowicz MK, Wittekind C, et al. TNM Classification of Malignant Tumours. 8th ed. Wiley- Blackwell; 2017. ISBN: 978-1-119-26357-9. 272 p.
Britten A, Rossier C, Taright N, et al. Genomic classifications and radiotherapy for breast cancer. Eur J Pharmacol.
;717(1-3):67-70. https://doi.org/10.1016/j.ejphar.2012.11.069
Mwafy SE, El-Guindy DM. Pathologic assessment of tumor-associated macrophages and their histologic localiza- tion in invasive breast carcinoma. J Egypt Natl Canc Inst. 2020;32(1):6. https://doi.org/10.1186/s43046-020-0018-8
Mahmoud SM, Lee AH, Paish EC, et al. Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol. 2012;65(2):159-163. https://doi.org/10.1136/jclinpath-2011-200355
Chen Y, Klingen TA, Aas H, et al. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. J Pathol Clin Res. 2023;9(3):151-164. https:// doi.org/10.1002/cjp2.309
Lindsten T, Hedbrant A, Ramberg A, et al. Effect of macrophages on breast cancer cell proliferation, and on expres- sion of hormone receptors, uPAR and HER-2. Int J Oncol. 2017;51(1):104-114. https://doi.org/10.3892/ijo.2017.3996
Khalili H, Dabiri S, Pourseyedi B, et al. Possible association of CD68-positive macrophages with other prognostic factors (Ki 67, ER, PR, HER2/neu) in primary breast cancer and axillary lymph node metastasis. J Kerman Univ Med Sci. 2017;24(6):459-466. ISSN: 1023-9510
Sari S, Özdemir Ç, Çilekar M. The relationship of tumour-associated macrophages (CD68, CD163, CD11c) and cancer stem cell (CD44) markers with prognostic parameters in breast carcinomas. Pol J Pathol. 2022;73(4):299- 309. https://doi.org/10.5114/pjp.2022.125424
Mwafy SE, El-Guindy DM. Pathologic assessment of tumor-associated macrophages and their histologic localiza- tion in invasive breast carcinoma. J Egypt Natl Canc Inst. 2020;32(1):6. https://doi.org/10.1186/s43046-020-0018-8
Hirschmann M, Schnellhardt S, Rübner M, et al. Prognostic significance of macrophage phenotypes in peri-tumor- al normal tissue of early-stage breast cancer. Cells. 2025;14(11):828. https://doi.org/10.3390/cells14110828
Lukianova N, Mushii O, Zadvornyi T, et al. Development of an algorithm for biomedical image analysis of the spatial organization of collagen in breast cancer tissue of patients with different clinical status. FEBS Open Bio. 2024;14(4):675-686. doi: https://doi.org/10.1002/2211-5463.13773
Chekhun V, Mushii O, Zadvornyi T, et al. Features of COL1A1 expression in breast cancer tissue of young patients.
Exp Oncol. 2023;45(3):351-363. https://doi.org/10.15407/exp-oncology.2023.03.351
Zadvornyi T, Lukianova N, Mushii O, et al. Benign and malignant prostate neoplasms show different spatial orga- nization of collagen. Croat Med J. 2023;64(6):413-420. https://doi.org/10.3325/cmj.2023.64.413
Zadvornyi T, Lukianova N, Borikun T, et al. Mast cells as a tumor microenvironment factor associated with the ag- gressiveness of prostate cancer. Neoplasma. 2022;69(6):1490-1498. https://doi.org/10.4149/neo_2022_221014N1020
Mushii O, Pavlova A, Bazas V, et al. Mast cells as a factor in regulation of breast cancer stromal component asso- ciated with breast cancer aggressiveness. Exp Oncol. 2025;46(4):311-323. https://doi.org/10.15407/exp-oncology. 2024.04.311
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
